Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · Real-Time Price · USD

6.90

+0.67 (10.75%)

At close: Mar 12, 2026, 4:00 PM EDT

6.82

-0.08 (-1.16%)

After-hours: Mar 12, 2026, 5:39 PM EDT

Atara Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	5.74	25.03	25.84	92.94	106.08	200.4
Short-Term Investments	7.97	17.47	25.88	149.88	264.98	300.26
Cash & Short-Term Investments	13.71	42.5	51.73	242.82	371.07	500.66
Cash Growth	-79.59%	-17.84%	-78.70%	-34.56%	-25.88%	93.22%
Accounts Receivable	1.91	1.48	34.11	40.22	0.99	1.25
Inventory	-	10.66	9.71	1.59	-	-
Other Current Assets	2.81	10.26	6.33	10.45	12.57	21.36
Total Current Assets	18.43	64.89	101.87	295.08	384.62	523.27
Net Property, Plant & Equipment	10.85	41.1	58.79	74.32	79.94	62.82
Other Long-Term Assets	0.88	3.1	4.84	7.02	3.57	2.03
Total Assets	30.17	109.1	165.5	376.42	468.13	588.12
Accounts Payable	0.32	4.37	3.68	6.87	17.37	7.12
Accrued Expenses	2.41	14.58	28.88	42.65	38.6	36.27
Unearned Revenue	1.01	95.09	77.83	8	40.76	33.46
Other Current Liabilities	14.32	20.54	31.83	21.39	9.06	6.06
Total Current Liabilities	18.06	134.57	142.23	78.92	105.79	82.9
Long-Term Leases	15.01	29.91	45.69	58.06	25.52	13.04
Other Long-Term Liabilities	33.74	41.89	76.82	112.8	57.21	29.84
Total Long-Term Liabilities	48.74	71.81	122.51	170.86	82.73	42.88
Total Liabilities	66.8	206.38	264.74	249.78	188.51	125.78
Common Stock	0	0	-	0.01	0.01	0.01
Additional Paid-in Capital	1,982	1,957	1,870	1,822	1,745	1,587
Accumulated Other Comprehensive Income	-	0	-0.2	-2.07	-0.37	0.3
Retained Earnings	-2,018	-2,055	-1,969	-1,693	-1,465	-1,125
Shareholders' Equity	-36.63	-97.28	-99.23	126.64	279.61	462.34
Total Liabilities & Equity	30.17	109.1	165.5	376.42	468.13	588.12
Total Debt	15.01	29.91	45.69	58.06	25.52	13.04
Net Cash (Debt)	-1.29	12.58	6.03	184.76	345.55	487.62
Net Cash Growth	-	108.59%	-96.73%	-46.53%	-29.13%	99.05%
Net Cash Per Share	-0.11	1.68	1.42	45.29	92.22	164.80
Book Value	-36.63	-97.28	-99.23	126.64	279.61	462.34
Book Value Per Share	-3.09	-12.99	-23.43	31.04	74.63	156.25
Tangible Book Value	-36.63	-97.28	-99.23	126.64	279.61	462.34
Tangible Book Value Per Share	-3.09	-12.99	-23.43	31.04	74.63	156.25

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q